An intercomparison exercise was conducted for the quantification of arsenic species in spiked human urine. The primary objective ofthe exercise was to determine the variance among laboratories in the analysis of arenic species such as inorganic As (As.3 and As5), monomethylarsonic acid (MMA), and dimethylarsinic add (DMA). Laboratories that paricipated had previous eprience with arsenic speciation analysis. The results of tis interlaboratory comparison are encouraging. There is relavely agreement on the concenraons of these areic sp in urine at concentrations that are relevant to research on the metabolism of arsenic in humans and other mammals. Both the accuracy and precision are relatively poor for arsenic concentrations of less than about 5 pg/l.
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Materials and Methods
Samples. A urine composite collected from three adults was frozen, thawed, and decanted to reduce the amount of suspended matter and then spiked with the concentrations of arsenic shown in Table 1 . The chemicals used to spike the urine included sodium arsenite and sodium arsenate (99.9% pure; Mallinckrodt, Phillipsburg, NJ), methane arsonic acid (no purity given; Ansul Inc., Marinette, WI), and sodium cacodylate (no purity given; Ted Pella, Inc., Redding, CA). The unspiked urine contained approximately 0.4 pg/l inorganic arsenic, 0.5 pg/l MMA, and 2 pg/l DMA.
After the urine was spiked, approximately 200-ml aliquots were frozen in polyethylene bottles and shipped on ice to seven laboratories by air courier. Included in the substance that can be measured and reported with 99% confidence that the analyte concentration is greater than zero and is determined from analysis of a sample in a given matrix containing the analyte (1)] reported by the participating laboratories are shown in Table 4 . Sample volumes used were not reported. The laboratories were able to quantify the arsenic species in all but a few cases in the Sample IA, the lowest spike sample.
For each sample type and species of arsenic, laboratories were compared using a one-way analysis-of-variance (ANOVA) on the natural logarithm transformed concentration. The transformation was conducted to reduce the inequality of the within-laboratory variances.
Results and Discussion
Each of the seven laboratories analyzed three types of samples: 1) known standard solutions of MMA and DMA; 2) known NIST SRM 2670; and 3) three spiked urine samples of unknown concentration. In most cases, the laboratories analyzed each sample in triplicate.
Laboratories analyzed two known methylated arsenic standard solutions that were distributed with the urine samples. These standards contained 10 ppm MMA and 10 ppm DMA as arsenic. The purpose was to determine whether there was bias among laboratories due to the availability of calibrating standards. The participating laboratories analyzed these two standards for either the methylated form and/or total arsenic. The results (Table 5) indicate that Articles * Arsenic speciation in human urine all laboratories agree within ± 19% on the nominal concentration of the methylated compounds. The three laboratories that analyzed these two standards for total arsenic were within ± 15% of the nominal value, except for one value of +37%.
The results for the analysis of the SRM 2670 for arsenic species are shown in Table  6 . This reference material was prepared by NIST by spiking inorganic arsenic into urine. Therefore, more than 80% of the arsenic is in the inorganic form. The mean total arsenic of 509 pg/l reported by the seven laboratories is in good agreement with the certified value of 480 ± 100 pg/l.
Both MMA and DMA were quantified by most laboratories. Laboratory Number 4 determined the inorganic arsenic to be arsenate (As+5). The sum of mean inorganic, MMA, and DMA was 487 pg/l, which is 15 pg/l less than the total arsenic determined by AAS or ICP-MS. This difference between total arsenic and the sum of the arsenic species detected could be due to other arsenic compounds in the urine that were not detected by most of the speciation methods used; methods for total arsenic may not detect all species of arsenic present in a sample. Laboratory Number 4, using HPLC-ICP-MS, reported approximately 30 pg/l of arsenobetaine.
The results from the analysis of the three spiked urine samples by the participating laboratories are shown in Table 7 . Each laboratory analyzed three replicates. Total As ( bSum of inorganic arsenic, MMA, and DMA. cTotal As determined by either atomic absorption or inductively coupled plasma-mass spectrometry. dResult is close to the method detection limit. 
